|
|
Gene Vaccines' z" U r& X" J4 ~- g9 N
Thalhamer, Josef; Weiss, Richard; Scheiblhofer, Sandra (Eds.)
; I& t* i) e& C2 G1st Edition., 2012, XI, 330 p. 49 illus., 41 in color.
, w# \+ t! O6 q9 a) Z# x% {" m; v. g$ ]0 C! x
Hardcover, ISBN 978-3-7091-0438-5
* l2 j+ a# W2 |& O. @" r7 e# j' f) TOnline orders shipping within 2-3 days
% b/ @' W7 L5 l5 p: p. A3 }/ E149,95
2 f5 S" a5 A0 r- d
1 S" m" }+ |$ C* q目录
3 O* j* K: Q& m7 G) N- ^* PPreface.- 1 General mechanisms of gene vaccines.- 2 Strategies to Improve DNA Vaccine Potency: HPV-associated Cervical Cancer as a Model System.- 3 Immune-activating mechanisms of replicase-based DNA and RNA vaccines and their role in immune-apoptosis.- 4 Cytokine genes as molecular adjuvants for DNA vaccines.- 5 Pharmaceutical non-viral formulations for gene vaccines.- 6 Rational design of formulated DNA vaccines: the DermaVir approach.- 7 In vivo electroporation.- 8 Electroporation-based Trigrid™ delivery system (TDS) for DNA vaccine administration.- 9 Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines.- 10 Intranodal genetic immunization.- 11 Immunotherapy of cancer with RNA vaccines.- 12 DNA and RNA vaccines for prophylactic and therapeutic treatment of type I allergy.- 13 Approved veterinary vaccines – paving the way to products for human use.- 14 Current status of regulations for DNA vaccines.- 15 State of the art production of antibiotic resistance-free plasmid DNA.- 16 Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy.
7 E [4 X+ S7 S2 n' g6 V, l( D8 t; y" d
下载地址:! I* n' I. Q; Q$ a, Q
% h' e, j: f1 S
* N! S7 t! G3 Y
|
|